Poor compliance with an antibiotic directive-A call for intensified monitoring.


Journal

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
ISSN: 1878-3511
Titre abrégé: Int J Infect Dis
Pays: Canada
ID NLM: 9610933

Informations de publication

Date de publication:
Mar 2021
Historique:
received: 26 11 2020
revised: 11 01 2021
accepted: 13 01 2021
pubmed: 20 1 2021
medline: 23 4 2021
entrez: 19 1 2021
Statut: ppublish

Résumé

In April 2017, the Central Denmark Region Antibiotic Stewardship Committee issued a directive to reduce the general use of piperacillin-tazobactam and prescribe narrow-spectrum antibiotics for mild and moderate pneumonia. The directive was distributed to all regional hospital clinicians. Electronic medical records were used to obtain de-identified details of all antibiotics administered (together with diagnosis codes) to all in-hospital patients (pre-directive and post-directive) in the nine regional hospitals. Average moving range statistical process control charts were used to analyze pre-directive and post-directive variation in antibiotic usage patterns. Upon the distribution of the directive, a period of decline of the overall usage of piperacillin-tazobactam ensued. Rather than benzylpenicillin, as recommended for pneumonia, the initial decline in piperacillin/tazobactam usage was accompanied by increased use of cefuroxime. A steward-directed reduction in piperacillin-tazobactam usage was accompanied by less desirable usage of a broad-spectrum alternative. Future antibiotic stewardship initiatives will hopefully benefit from close monitoring and timely feedback to clinicians. A dialogue with clinicians based on near real-time data is predicted to improve antibiotic stewardship actions.

Sections du résumé

BACKGROUND BACKGROUND
In April 2017, the Central Denmark Region Antibiotic Stewardship Committee issued a directive to reduce the general use of piperacillin-tazobactam and prescribe narrow-spectrum antibiotics for mild and moderate pneumonia. The directive was distributed to all regional hospital clinicians.
METHODS METHODS
Electronic medical records were used to obtain de-identified details of all antibiotics administered (together with diagnosis codes) to all in-hospital patients (pre-directive and post-directive) in the nine regional hospitals. Average moving range statistical process control charts were used to analyze pre-directive and post-directive variation in antibiotic usage patterns.
RESULTS RESULTS
Upon the distribution of the directive, a period of decline of the overall usage of piperacillin-tazobactam ensued. Rather than benzylpenicillin, as recommended for pneumonia, the initial decline in piperacillin/tazobactam usage was accompanied by increased use of cefuroxime.
CONCLUSIONS CONCLUSIONS
A steward-directed reduction in piperacillin-tazobactam usage was accompanied by less desirable usage of a broad-spectrum alternative. Future antibiotic stewardship initiatives will hopefully benefit from close monitoring and timely feedback to clinicians. A dialogue with clinicians based on near real-time data is predicted to improve antibiotic stewardship actions.

Identifiants

pubmed: 33465487
pii: S1201-9712(21)00039-4
doi: 10.1016/j.ijid.2021.01.029
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Piperacillin, Tazobactam Drug Combination 157044-21-8

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

474-478

Informations de copyright

Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.

Auteurs

Frederik Novak (F)

Department of Infectious Diseases, Aarhus University Hospital, Skejby, Aarhus, Denmark.

Jens T Hørlück (JT)

DEFACTUM, Central Denmark Region, Aarhus, Denmark.

Jacob D Redder (JD)

Business Intelligence Office, Department of Information Technology, Central Denmark Region, Aarhus, Denmark.

Paul W Denton (PW)

Department of Infectious Diseases, Aarhus University Hospital, Skejby, Aarhus, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark; Universityof Nebraska at Omaha, Department of Biology, Omaha, Nebraska, USA.

Merete Storgaard (M)

Department of Infectious Diseases, Aarhus University Hospital, Skejby, Aarhus, Denmark. Electronic address: merestor@rm.dk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH